Vaxxas micropatch vaccine COVID-19
Vaxxas’ patch comes in a hockey-puck-shaped applicator with a foil seal. [Image courtesy of Vaxxas]

Vaxxas announced today that it was granted an exclusive license to a next-generation COVID-19 vaccine for use with its delivery patch.

Cambridge, Massachusetts-based Vaxxas received the exclusive license from The University of Texas at Austin for its HexaPro SARS-CoV-2 spike subunit vaccine.

Get the full story at our sister site, Drug Delivery Business News.